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Abstract 
Conventional dendritic cells (cDCs) are essential immune cells linking the innate 
and adaptive immune system. cDC depletion in mice is an important method to 
study the function of these cells in vivo. Here we report an inducible in vivo 
system for cDC depletion in which excision of a loxP flanked Stop signal enables 
expression of the human diphtheria toxin receptor (DTR) under the control of 
Zbtb46 (zDClSlDTR). cDCs can be specifically depleted by combining zDClSlDTR 
mice with a Csf1rCre driver line. In addition, we show that zDCCre mice can be 
used to produce cDC specific conditional knockout mice (Irf8, Irf4, Notch2) which 
lack specific subsets of cDCs.  
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Introduction 
Expression of Itgax (CD11c) has been widely used as a marker for conventional 
dendritic cells (cDCs) and to target these cells (Caton et al., 2007; Jung et al., 
2002; Lindquist et al., 2004; Stranges et al., 2007). However, pDCs, NK cells, 
activated monocytes, macrophages, and some lymphocytes also express CD11c 
limiting its use and complicating the interpretation of experiments using CD11c 
as a marker or for cDC depletion.  
 
We previously described that a two-gene approach using LysM and Csf1r 
expression can be used to specifically deplete monocytes, monocyte-derived 
cells, and macrophages (Schreiber et al., 2013). The discovery of a cDC 
restricted transcription factor Zbtb46 (zDC) provides an alternative means to 
identify and target pre-DC derived cDCs (Meredith et al., 2012; Satpathy et al., 
2012). Mice that carry the green fluorescent protein under the control of the zDC 
gene (zDCGFP) show GFP expression specifically in cDCs (Satpathy et al., 2012) 
and zDCDTR mice can be used to deplete cDCs sparing other hematopoietic cells 
(Meredith et al., 2012). Here we describe a method for inducible depletion of 
cDCs; expression of the human diphtheria toxin receptor (DTR) under the control 
of the zDC gene is inhibited by a loxP flanked transcriptional Stop cassette 
(zDClSlDTR).  
 
Mice that express the Cre recombinase under the control of the zDC gene 
represent an additional tool for cDC targeting (Loschko et al., 2016). To examine 
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its possible uses we have combined zDCCre mice with mice carrying loxP flanked 
IRF8, IRF4 and Notch2, respectively.  
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Material and methods 
Mice 
zDClSlDTR knockin mice were produced by homologous recombination in C57BL/6  
albino embryonic stem cells at The Rockefeller University Gene Targeting 
Resource Center. The targeting strategy was the same as for the previously 
described zDCDTR mice (Meredith et al., 2012). zDClSlDTR mice were maintained 
on an albino C57BL/6 background. Csf1rCre BAC transgenic mice were produced 
by DNA microinjection into mouse oocytes. Irf4fl/fl (IRF4fl/fl, stock number 9380), 
Irf8fl/fl (IRF8fl/fl, stock number 14175), Notch2fl/fl (Notch2fl/fl, stock number 10525), 
Rosa26lSlYFP (Rosa26lSlYFP, stock number 6148) mice were purchased from The 
Jackson Laboratory. All mice were housed in The Rockefeller University 
Comparative Bioscience Center under specific pathogen free conditions. All 
experiments were performed in accordance with the National Institutes of Health 
guidelines and approved by The Rockefeller University Animal Care and Use 
Committee.  
 
DT injections 
For transient cDC depletion mice were injected i.p. with 500 ng DT (Sigma) on 
the first day and 100 ng on all subsequent days. To analyze cell depletion mice 
were euthanized 16 hours after DT injection. For long-term cDC depletion DT 
was injected every other day. 
 
Flow cytometry  
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For FACS analysis, cells were stained using antibodies against B220 (RA3-6B2), 
BST2 (eBio927), F4/80 (BM8), Gr-1 (RB6-8C5), Ly6C (AL-21), Ly6G (1A8), 
MHCII (M5/114.15.2), NK1.1 (PK136), Siglec-H (440c), CD3 (145-2C11), CD4 
(RM4-5), CD8 (53-6.7), CD11b (M1/70), CD11c (N418), CD19 (1D3), CD115 
(AFS98). PI (Sigma), DAPI (Invitrogen) or Aqua live/dead (Invitrogen) was added 
to exclude dead cells from analysis. Cells were analyzed on a LSR Fortessa flow 
cytometer (BD Biosciences). Analysis was performed using FlowJo software 
(Tree Star).  
 
BM and spleen cell isolation 
For isolation of mononuclear phagocytes spleens were mechanically disrupted 
and incubated with HBSS (Gibco) + 5% FBS + 0.5 mg/mL CollagenaseD (Roche) 
at 37 °C for 30 min. Cells were filtered through 100 µM cell strainers and washed. 
Erythrocytes were lysed with ACK Lysing buffer (Gibco). BM cells were isolated 
from femurs and tibiae and filtered through 100 µM cell strainers. Erythrocytes 
were lysed with ACK Lysing buffer (Gibco). 
 
ELISA 
Serum levels of Flt3L were determined by ELISA (R&D Systems) according to 
the manufacturer’s protocol 
 
Statistical Analysis 
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Results are shown as a means + SEM. Comparisons between groups were done 
using Student’s two-tailed t test analysis. Statistical significance was determined 
as P values <0.05.  
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Results 
The MNP lineage 
Dendritic cells (DCs), monocytes, and macrophages are closely related and 
together comprise the mononuclear phagocyte (MNP) system. In mice the 
macrophage-DC progenitor (MDP) in the bone barrow (BM) gives rise to 
monocytes and a common DC progenitor (CDP). Monocytes circulate in the 
blood and peripheral tissues where they can be activated and develop into 
“inflammatory” DCs and some but not all types of macrophages (Hashimoto et 
al., 2013). CDPs give rise to plasmacytoid DCs (pDCs) and pre-DCs, progenitor 
cells that are committed to become cDCs (Liu et al., 2009). Both pDCs and pre-
DCs leave the BM and seed lymphoid and non-lymphoid tissues (Geissmann et 
al., 2010). Pre-DCs differentiate into cDCs that can be divided into CD8α+ and 
CD11b+ cDCs, respectively (Fig. 1 and (Hildner et al., 2008; Lewis et al., 2011; 
Tamura et al., 2005)). In mice, pre-DCs appear to be heterogeneous and can be 
divided into cells committed to become CD8α+ or CD11b+ cDCs, respectively 
(Grajales-Reyes et al., 2015; Schlitzer et al., 2015). 
 
zDClSlDTR and Csf1rCre mice 
zDC is expressed in cDCs and their immediate committed precursors but not in 
other cells of the MNP system (Fig. 1 and (Meredith et al., 2012; Satpathy et al., 
2012)). zDC has been used to deplete (zDCDTR), label (zDCGFP) and target 
(zDCCre) cDCs (Loschko et al., 2016; Meredith et al., 2012; Satpathy et al., 2012). 
However, zDC is also expressed in endothelial cells. Therefore, prolonged cDC 
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depletion in zDCDTR mice by diphtheria toxin (DT) injection requires the use of 
bone marrow chimeras (BMC). To produce an inducible zDCDTR mouse, we 
inserted a loxP flanked transcriptional Stop element in front of the DTR, and 
inserted the cassette into the zDC gene (zDClSlDTR) (Fig. 2). Cre mediated 
excision of the Stop element results in DTR expression under the control of the 
zDC promoter.  
 
To restrict DTR expression to cDCs in zDClSlDTR mice, we chose BAC transgenic 
mice expressing Cre under the control of the Csf1 receptor gene (Csf1rCre, Fig. 
3A). Csf1r is expressed in monocytes, macrophages, and DC precursors (MDP 
and CDP) (Fig. 1). To determine the specificity of Cre expression in Csf1rCre mice 
we crossed Csf1rCre to Rosa26lSlYFP mice. Because pre-DCs descend from 
Csf1r+ CDPs we reasoned that pre-DCs in the BM as well as in the spleen of 
Csf1rCreRosa26lSlYFP mice should be labeled with YFP. As expected, all pre-DCs 
and cDCs were YFP+ (Fig. 3B). In addition, we found YFP expression in pDCs, 
monocytes and macrophages in Csf1rCreRosa26lSlYFP mice since these cells also 
descend from Csf1r+ precursor cells or express Csf1r, respectively (Fig. 3B). The 
percentage of labeled pDCs was lower than in cDCs, macrophages and 
monocytes possibly because pDCs can develop from myeloid as well as 
lymphoid precursors (Sathe et al., 2013). Thus, although Cre expression in 
Csf1rCre mice is not specific for cDCs, cDCs are efficiently targeted in these mice 
(near 100% recombination efficiency) and therefore Csf1rCre mice are suitable for 
cDC targeting. 
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Csf1rCrezDClSlDTR mice 
Hemizygous Csf1rCre were bred to homozygous zDClSlDTR mice to obtain Cre+ 
(Csf1rCre+zDClSlDTR) and Cre- control (Csf1rCre-zDClSlDTR) littermates (Fig. 4A). 16 
hours after DT administration we found efficient depletion of cDCs but not 
monocytes, macrophages, CD8+ T or B cells (Fig. 4B). We observed slightly 
lower levels of pDCs and CD4+ T cells in Csf1rCre+zDClSlDTR mice (Fig. 4B). 
However, we believe that these cells were not directly depleted by DT as they do 
not express zDC and hence do not express the DTR.  
 
Expression of zDC in endothelial cells requires the use of BMC to deplete cDCs 
in zDCDTR mice (Meredith et al., 2012); otherwise zDCDTR mice die 24-48 hours 
after DT injection (Meredith et al., 2012). In Csf1rCre+zDClSlDTR mice expression of 
DTR under the control of zDC is restricted to cells that descend from Csf1r 
expressing precursors. This approach omits endothelial cells. Among 
hematopoietic cells cDCs are the only cells expressing zDC and therefore DTR 
expression in Csf1rCre+zDClSlDTR mice is restricted to these cells. Therefore cDCs 
can be efficiently depleted for at least 4 weeks directly in these mice without the 
requirement to produce BMC (Fig. 4C).  
 
As previously demonstrated cDC depletion results in elevated levels of Flt3L (Fig. 
4D and (Birnberg et al., 2008; Meredith et al., 2012)); this has been associated 
with a myeloproliferative disorder (Birnberg et al., 2008). We also observed 
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elevated levels of neutrophils and monocytes in the spleen of mice depleted of 
cDCs for 4 weeks (Fig. 4E). This “side-effect” has to be kept in mind when 
depleting cells for a prolonged period of time. We conclude that 
Csf1rCre+zDClSlDTR mice can be used to efficiently deplete cDCs in vivo. 
 
cDC specific conditional knockout mice lacking cDC subsets 
cDCs can be divided into two subsets; IRF8/Batf3 dependent CD8α+ cDCs and 
IRF4/Notch2 dependent CD11b+ DCs (Hildner et al., 2008; Lewis et al., 2011; 
Tamura et al., 2005). To test whether the two cDC subsets can be depleted using 
zDCCre mice we crossed them with IRF8fl/fl, IRF4fl/fl or Notch2fl/fl mice and 
compared Cre- and Cre+ littermates. zDCCre+IRF8fl/fl mice had normal frequencies 
of pDCs and cDCs in the spleen (Fig. 5A, B). However, they had significantly 
fewer CD8α+/DEC205+ cDCs compared to their Cre- littermates (Fig. 5A, C). We 
conclude that zDCCre mice can be used to conditionally delete Irf8 expression in 
cDCs to produce mice deficient in the CD8α+/DEC205+ cDC subset. 
 
In contrast, zDCCre+Notch2fl/fl as well as zDCCre+IRF4fl/fl mice did not show 
reduced frequencies of CD8α+ cDCs. However, we detected lower percentages 
of CD11b+ cDCs in these mice. Some CD11b+ cDCs also express CD4, ESAM 
and DCIR2, respectively. We found fewer cells expressing these markers in 
zDCCre+Notch2fl/fl and zDCCre+IRF4fl/fl mice indicating that Notch2 and IRF4 are 
required for full differentiation of CD11b+ cDCs (Fig. 6A, C, D, F). In IRF4fl/fl mice 
expression of GFP marks cells with recombined loxP sites (Klein et al., 2006). 
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Analyzing GFP expression showed that in the majority of cDCs loxP sites 
recombined. Therefore, the reason for incomplete absence of CD11b+ cDCs 
cannot be inefficient recombination and IRF4 deletion. More likely Cre mediated 
deletion of IRF4 happens at a time during cDC differentiation where IRF4 is 
already at least partially dispensable. 
 
We conclude that zDCCre mice can be used to deplete CD8α+ cDCs 
(zDCCre+IRF8fl/fl) and produce mice that show reduced frequencies albeit not 
complete deletion of CD11b+ cDCs (zDCCre+Notch2fl/fl and zDCCre+IRF4fl/fl). 
Whether the remaining CD11b+ cDCs in zDCCre+Notch2fl/fl and zDCCre+IRF4fl/fl 
mice show functional impairment has to be investigated.  
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Discussion 
Gene targeting is an essential tool to study the function of cDCs in vivo. A 
frequent limitation of these in vivo models is partial specificity. Until recently 
CD11c expression was the most specific marker to target cDCs. CD11c has 
been used to label (CD11cYFP), deplete (CD11cDTR), and conditionally target 
(CD11cCre) cDCs (Caton et al., 2007; Jung et al., 2002; Lindquist et al., 2004; 
Stranges et al., 2007). However, CD11c expression is not restricted to cDCs but 
also found in pDCs, activated monocytes, macrophages and some NK cells. 
(Hohl et al., 2009; Meredith et al., 2012; Schreiber et al., 2013; Serbina et al., 
2003).  
 
Among hematopoietic cells expression of zDC is restricted to cDCs (Meredith et 
al., 2012; Satpathy et al., 2012). However, endothelial cells express zDC as well 
(Satpathy et al., 2012), and therefore zDCDTR mice die after DT administration. 
The inducible zDClSlDTR mouse described here allows prolonged depletion of 
cDCs in non-BMC mice, which is a significant improvement. The same inducible 
zDClSlDTR mouse can also be used to deplete cDC subsets when combined with 
Cre driver lines that are specific for CD8α+ and CD11b+ cDCs, respectively. 
Potential candidate genes include Xcr1, Ly75 (DEC205), Itgam (CD11b), and 
Clec4a4 (Dcir2). The available CD4Cre and CD8Cre mice have been tested but 
proved to be not useful for targeting cDCs (data not shown). 
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An alternative approach to deplete cDC subsets is to produce cDC specific 
conditional knockouts. Mice lacking IRF8 in cDCs (zDCCre+IRF8fl/fl) for example 
lack CD8α+ cDCs. Although Batf3 deficient mice also lack CD8α+ cDCs (Hildner 
et al., 2008) compensatory mechanisms can lead to Batf3 independent CD8α+ 
cDC development (Tussiwand et al., 2012). zDCCre+IRF8fl/fl mice provide a 
valuable tool to study the contribution of CD8α+ cDCs during immune activation 
(Esterhazy et al., 2016). 
 
Although IRF4 deficient mice lack CD4+ cDCs (Tamura et al., 2005) 
zDCCre+Notch2fl/fl and zDCCre+IRF4fl/fl mice are only partially deficient in 
CD11b+/CD4+ cDCs. This discrepancy could be due to timing of deletion. In 
zDCCre+RosalSlYFP mice pre-DCs are YFP- (data not shown) whereas pre-DCs in 
zDCGFP mice are GFP+ (Satpathy et al., 2012). We speculate that by the time the 
loxP sites have recombined and YFP starts getting expressed the cells already 
became MHCII+ cDCs. In case of zDCCre+Notch2fl/fl and zDCCre+IRF4fl/fl mice this 
would mean that differentiation of cDCs might be complete before deletion of 
Notch2 and IRF4, respectively and that zDC expressing cells are not dependent 
on Notch2 or IRF4 for their final differentiation. Another explanation for the 
presence of CD11b+ cDCs in zDCCre+Notch2fl/fl and zDCCre+IRF4fl/fl mice could be 
incomplete deletion or that mRNA and/or protein have a long half-life. IRF4 
deficient cDCs were described to be functionally impaired (Vander Lugt et al., 
2014). Whether CD11b+ cDCs are functionally defective in zDCCre+IRF4fl/fl mice 
remains to be investigated. 
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Fig. 1. The MNP network. The macrophage-DC progenitor (MDP) resides in the 
bone barrow and gives rise to monocytes (mono) and common DC progenitors 
(CDP). Monocytes circulate in the blood and can differentiate into “inflammatory” 
DCs and some but not all macrophages after activation. CDPs are restricted to 
become pDCs or pre-DCs. Both cells seed peripheral tissues. pre-DCs become 
CD8α+ and CD11b+ cDCs, respectively. Cells expressing Csf1r and zDC, 
respectively, are labeled accordingly. 
 
Fig. 2. Generation of the zDClSlDTR mouse. Schematic diagram of the Zbtb46 
(zDC) locus. 5’ and 3’ UTRs are shown in black, coding regions in white. A 
transcriptional Stop element flanked by loxP sites and followed by the sequence 
encoding for IRES-DTR-mCherry was introduced in the 3’UTR of zDC right after 
the endogenous Stop codon. After Cre mediated recombination of loxP sites the 
DTR-mCherry fusion protein is expressed under the control of the zDC promoter. 
 
Fig. 3. Fate mapping using a BAC transgenic Csf1rCre mouse. (A) Schematic 
diagram of the Csf1r locus. 3’ UTR is shown in black, coding regions in white. To 
express Cre recombinase in cells that actively transcribe Csf1r, we inserted 
IRES-Cre into the 3’ UTR of Csf1r right after the endogenous Stop codon. (B) 
Dot plots show gating strategy in the spleen to define pDCs, cDCs, pre-DCs, 
RPMs and monocytes. pDCs (BST2+CD11c+), cDCs (BST2-Lin-
CD11chighMHCII+), pre-DCs (BST2-Lin-CD11c+MHCII-Flt3+Sirpα-), RPM (Lin-
CD11blow F4/80+), monocytes (Lin-CD11b+F4/80-Ly6G-Ly6C+CD115+). 
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Histograms show percentage of cells expressing YFP in Csf1rCreRosalSlYFP mice 
(open histograms) or RosalSlYFP control mice (filled grey histograms). Graph 
depicts percentage of indicated cells expressing YFP. 
 
Fig. 4. Csf1rCrezDClSlDTR mice. (A) Hemizygous Csf1rCre mice were bred with 
homozygous zDClSlDTR mice. Resulting offspring consists of Cre- control (Csf1rCre-
zDClSlDTR) and Cre+ (Csf1rCre+zDClSlDTR) mice. (B) 500 ng DT was injected i.p.; 16 
hours later spleens were isolated and cDC depletion was determined by flow 
cytometry. Graphs depict percentage of pDCs, cDCs, monocytes, macrophages, 
T and B cells among living splenocytes. Each data point represents one 
individual mouse (n=5-8). (C, D) Mice received 500 ng DT the first day and 100 
ng every other day thereafter for 4 weeks. (C) Graph depicts percentage of pDCs 
and cDCs among living splenocytes. Each data point represents one individual 
mouse (n=10-11) (D) Graph depicts serum levels of Flt3L in pg/mL. Each data 
point represents one individual mouse (n=10-11). (E) Graphs depict percentage 
of neutrophils and monocytes among living splenocytes. Each data point 
represents one individual mouse (n=10-11). * P value < 0.05 
 
Fig. 5. zDCCreIRF8fl/fl mice. (A) Flow cytometric analysis of splenocytes from Cre- 
(zDCCre-IRF8fl/fl) and Cre+ (zDCCre+IRF8fl/fl) mice. (B) Graph depicts frequency of 
pDCs and cDCs among living splenocytes. (C) Graph depicts ratio of CD8α+, 
DEC205+ and CD11b+ cDCs. Each data point represents one individual mouse 
(n=9). * P value < 0.05 
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Fig. 6. zDCCreNotch2fl/fl and zDCCreIRF4fl/fl mice. (A) Flow cytometric analysis of 
splenocytes from Cre- (zDCCre-Notch2fl/fl) and Cre+ (zDCCre+Notch2fl/fl) mice. (B) 
Graph depicts frequency of pDCs and cDCs among living splenocytes. Each data 
point represents one individual mouse (n=8). (C) Graph depicts ratio of CD8α+, 
CD11b+, CD4+, ESAM+ and DCIR2+ cDCs. Each data point represents one 
individual mouse (n=7-8). (D) Flow cytometric analysis of splenocytes from Cre- 
(zDCCre-IRF4fl/fl) and Cre+ (zDCCre+IRF4fl/fl) mice. (E) Graph depicts frequency of 
pDCs and cDCs among living splenocytes. Each data point represents one 
individual mouse (n=10). (F) Graph depicts ratio of CD8α+, CD11b+, CD4+, 
ESAM+ and DCIR2+ cDCs. Each data point represents one individual mouse 
(n=6-10). * P value < 0.05 
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